Leonard G. Gomella, MD
An increased understanding of the genetic makeup of prostate cancer could allow for the introduction of more effective therapies for patients who develop advanced disease, said Leonard G. Gomella, MD. However, how to best use genetic testing to screen potentially at-risk patients early on remains unclear.
The role of genetic testing is finding its way right now. We know much more about using these tests in women with breast cancer,” said Gomella, a professor and chair of the Department of Urology and director of the Sidney Kimmel Cancer Center Network and Thomas Jefferson University Hospital. “We are still trying to figure out how to best use these methods in prostate cancer.”
... to read the full story